Fecal incontinence and associated pelvic floor dysfunction during and one year after the first pregnancy.

anal incontinence fecal incontinence incomplete bowel evacuation obstructed defecation pelvic organ prolapse prospective cohort study vaginal bulging

Journal

Acta obstetricia et gynecologica Scandinavica
ISSN: 1600-0412
Titre abrégé: Acta Obstet Gynecol Scand
Pays: United States
ID NLM: 0370343

Informations de publication

Date de publication:
08 2023
Historique:
revised: 28 05 2023
received: 24 01 2023
accepted: 03 06 2023
medline: 31 7 2023
pubmed: 20 6 2023
entrez: 20 6 2023
Statut: ppublish

Résumé

Obstetric anal sphincter injury is an important risk factor for postpartum fecal incontinence but few studies have reported fecal incontinence occurring, even during pregnancy. The first objective of this study was to examine the prevalence of fecal incontinence, obstructed defecation and vaginal bulging early and late in pregnancy and postpartum. The second objective was to assess the association between symptoms in pregnancy, delivery characteristics, and bowel and vaginal bulging symptoms at 1 year postpartum. This prospective cohort study was conducted between October 2014 and October 2017, including 898 nulliparous women enrolled with the maternity healthcare service in Örebro County, Sweden. The women responded to questionnaires regarding pelvic floor dysfunction in early and late pregnancy and at 8 weeks and 1 year postpartum. The data were analyzed using random effect logistic models estimating odds ratios (ORs) and generalized linear models estimating relative risks, with 95% confidence intervals (CIs). At 1 year postpartum, the prevalence of fecal incontinence, obstructed defecation and vaginal bulging was 6% (40/694), 28% (197/699) and 8% (56/695), respectively. Among women with vaginal delivery, the risk of fecal incontinence and vaginal bulging increased significantly both in late pregnancy, with ORs of 3.4 (95% CI 1.5-7.7) and 3.6 (95% CI 1.6-8.1), respectively, and at 1 year postpartum, with ORs of 5.0 (95% CI 2.1-11.5) and 8.3 (95% CI 3.8-18.1), respectively, compared with early pregnancy. Among all women, factors associated with increased prevalence of fecal incontinence 1 year postpartum were fecal incontinence during pregnancy (adjusted relative risk [aRR] 7.4; 95% CI 4.1-13.3), obstructed defecation during pregnancy (aRR 2.0; 95% CI 1.1-3.9) and concurrent obstructed defecation (aRR 2.4; 95% CI 1.3-4.5). This prospective study shows an increased risk of fecal incontinence by late pregnancy, suggesting that the pregnancy itself may be involved in the development of postpartum fecal incontinence. Obstructed defecation during pregnancy and postpartum was found to be associated with increased risk of fecal incontinence postpartum, indicating that postpartum fecal incontinence may be a result of incomplete bowel emptying.

Identifiants

pubmed: 37338103
doi: 10.1111/aogs.14614
pmc: PMC10378031
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1034-1044

Subventions

Organisme : Region Örebro län
ID : OLL-930507
Organisme : Region Örebro län
ID : OLL-939402
Organisme : Region Stockholm
ID : ALF Funding
Organisme : Svenska Läkaresällskapet
ID : SLS-250351
Organisme : Universitetssjukhuset Örebro
ID : OLL-410421

Informations de copyright

© 2023 The Authors. Acta Obstetricia et Gynecologica Scandinavica published by John Wiley & Sons Ltd on behalf of Nordic Federation of Societies of Obstetrics and Gynecology (NFOG).

Références

BJOG. 2006 Mar;113(3):264-7
pubmed: 16487196
Int Urogynecol J. 2017 Nov;28(11):1701-1707
pubmed: 28417155
Acta Obstet Gynecol Scand. 2011 May;90(5):483-7
pubmed: 21306343
BJOG. 2013 Jan;120(2):152-160
pubmed: 23121158
Acta Obstet Gynecol Scand. 2019 Jan;98(1):51-60
pubmed: 30204238
BMC Pregnancy Childbirth. 2020 Dec 2;20(1):749
pubmed: 33267813
Int Urogynecol J Pelvic Floor Dysfunct. 2006 May;17(3):224-30
pubmed: 16077997
BJOG. 2020 Nov;127(12):1499-1506
pubmed: 32418309
Birth. 2005 Sep;32(3):203-6
pubmed: 16128974
Aging Clin Exp Res. 2017 Dec;29(6):1165-1171
pubmed: 28120284
Am J Obstet Gynecol. 2019 Nov;221(5):480.e1-480.e10
pubmed: 31128111
Colorectal Dis. 2008 Oct;10(8):793-9
pubmed: 18266886
J Midwifery Womens Health. 2015 Jan-Feb;60(1):37-47
pubmed: 25712278
J Clin Epidemiol. 2005 Jan;58(1):41-6
pubmed: 15649669
Acta Obstet Gynecol Scand. 2021 Dec;100(12):2193-2201
pubmed: 34699060
Am J Gastroenterol. 2004 Nov;99(11):2204-9
pubmed: 15555003
Obstet Gynecol. 2012 Feb;119(2 Pt 1):240-9
pubmed: 22270274
Int Urogynecol J. 2017 Jan;28(1):5-31
pubmed: 27774569
Int Urogynecol J. 2022 Jun;33(6):1567-1582
pubmed: 34973088
Neurourol Urodyn. 2010;29(1):4-20
pubmed: 19941278
Int Urogynecol J. 2019 Mar;30(3):477-482
pubmed: 29656330
Int Urogynecol J. 2021 Jul;32(7):1825-1832
pubmed: 33646348
Annu Rev Clin Psychol. 2010;6:79-107
pubmed: 20192796
Acta Obstet Gynecol Scand. 2023 Aug;102(8):1034-1044
pubmed: 37338103
Acta Obstet Gynecol Scand. 2018 Apr;97(4):466-476
pubmed: 29172245
BJOG. 2016 Apr;123(5):821-9
pubmed: 26113145
Int Urogynecol J. 2013 Sep;24(9):1473-9
pubmed: 23229419
Int Urogynecol J. 2018 Mar;29(3):441-448
pubmed: 28698892
Am J Obstet Gynecol. 2019 Jul;221(1):41.e1-41.e7
pubmed: 30885773

Auteurs

Markus Harry Jansson (MH)

Department of Obstetrics and Gynecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
School of Medical Sciences, Faculty of Health and Medicine, Örebro University, Örebro, Sweden.
Department of Clinical Sciences, Danderyd Hospital, Karolinska Institute, Stockholm, Sweden.

Karin Franzén (K)

School of Medical Sciences, Faculty of Health and Medicine, Örebro University, Örebro, Sweden.

Gunilla Tegerstedt (G)

Unit of Obstetrics and Gynecology, CLINTEC, Karolinska University Hospital at Huddinge, Karolinska Institute, Stockholm, Sweden.

Jan Brynhildsen (J)

Department of Obstetrics and Gynecology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
School of Medical Sciences, Faculty of Health and Medicine, Örebro University, Örebro, Sweden.

Ayako Hiyoshi (A)

Clinical Epidemiology and Biostatistics, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.

Kerstin Nilsson (K)

School of Medical Sciences, Faculty of Health and Medicine, Örebro University, Örebro, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH